(Q57139697)

English

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

No description defined

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

0 references

0 references

1 reference

Europe PubMed Central

title

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal? (English)

0 references

1 reference

stem cell transplantation

1 reference

Yee Chung Cheng

1

0 references

Naoto T Ueno

series ordinal

2

0 references

language of work or name

English

0 references

publication date

July 2010

0 references

published in

Women's Health

0 references

volume

6

0 references

issue

4

0 references

page(s)

481-5

0 references

cites work

Cancer statistics, 2009

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and N

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chem

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and onl

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FWHE.10.31

retrieved

21 January 2018

Identifiers

DOI

10.2217/WHE.10.31

0 references

PubMed publication ID

20597609

0 references

(Q57139697)

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)